Riskpilot← Back to searchSign inGet full accessWAI GENETICS AS
ASActiveOrg 925170291Kåre Johan Teigen Dramsvegen 147B, 9010 TromsøResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20201 employees
Revenue 2024
NOK 108K
+5% vs 2023
EBITDA margin
-2255.1%
-2087% vs 2023
Equity ratio
94.2%
Financial strength
Net profit 2024
NOK 482K
+12178% vs 2023
| Revenue | NOK 108K | +5% |
| EBITDA | NOK -2,4M | -2087% |
| Net profit | NOK 482K | +12178% |
| Total assets | NOK 74,6M | +693% |
| Equity | NOK 70,2M | +1070% |
| Employees | 1 | — |
Legal name
WAI GENETICS AS
Org number
925170291
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
9. juni 2020
Share capital
NOK 30 030
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Undersøke og utvikle nyskapende forbindelser og verktøy for genetisk, biokjemisk og bioteknologisk industri. Disse produktene som utvikles, vil bli produsert av oss eller delvis outsourcet. Vi vil selge de ferdige bioteknologiske verktøyene våre til forskjellige bioteknologiske selskaper og forskningsinstitusjoner. Først og fremst vil vi selge våre egne utviklede produkter, men vi vil også lage en plattform med detaljhandel og videresalg av eksisterende bioteknologiske produkter fra andre produsenter. Gjennom vårt selskap vil vi også gi rådgivning innen bioteknologi og da drive undervisning og konsulentvirksomhet.
Address
Kåre Johan Teigen Dramsvegen 147B, 9010 Tromsø
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 103 | 242 | 429 | 103 | 108 |
| Staff expenses | −0 | −0 | −119 | −127 | −444 |
| EBITDA | 86 | 100 | −31 | −111 | −2 436 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 86 | 100 | −31 | −111 | −2 436 |
| Net financials | 0 | 0 | 35 | 107 | 3 105 |
| Profit before tax | 86 | 100 | 4 | −4 | 669 |
| Tax | −0 | −0 | −0 | −0 | 188 |
| Net profit | 86 | 100 | 25 | −4 | 482 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 378 | 2 825 | 5 537 | 9 403 | 74 571 |
| Equity | 81 | 420 | 2 030 | 6 000 | 70 211 |
| Long-term debt | 821 | 821 | 821 | 2 404 | 4 360 |
| Short-term debt | 476 | 1 584 | 2 686 | 999 | 0 |
| Total debt | 1 297 | 2 405 | 3 507 | 3 403 | 4 360 |
EBITDA margin
-2255.1%
This company
15.8%
Market median
-14373% vs market
20202024
Equity ratio
94.2%
This company
38.2%
Market median
+147% vs market
20202024
Return on equity
0.7%
This company
18.4%
Market median
-96% vs market
20202024
Net profit margin
446.2%
This company
8.1%
Market median
+5409% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
IS Contact Person | Contact Person | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 23.78% | 23.78% | 2024 | |
| Individual | 6.24% | 6.24% | 2024 | |
| Individual | 5.31% | 5.31% | 2023 | |
Andrija Stefanovic | Company | 5.18% | 5.18% | 2024 |
| Individual | 2.12% | 2.12% | 2024 | |
| Individual | 2.18% | 2.18% | 2024 | |
| Company | 1.33% | 1.33% | 2024 | |
| Company | 1.15% | 1.15% | 2024 | |
| Individual | 0.98% | 0.98% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of WAI GENETICS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ingvild Steinnes Sønvisen | Contact Person | 0 companies |
| Petter Johansen | Chairman | 0 companies |